Familial Lipoprotein Lipase Deficiency Latest Advances
Find the Latest Research About Familial Lipoprotein Lipase Deficiency
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 880 publications
Content validity of the Familial Chylomicronemia Syndrome Symptoms and Impacts Scale (FCS-SIS) for severe hypertriglyceridemia (sHTG).
Journal: Patient related outcome measures
Published: September 04, 2026
Olezarsen and Plozasiran: Novel apoC-III targeting medications for the treatment of hypertriglyceridemia.
Journal: Journal of cardiovascular pharmacology
Published: July 06, 2026
Familial Chylomicronemia Syndrome Due to a Homozygous LPL c.644G>A Variant and Response to Volanesorsen in Colombia: A Case Report.
Journal: Cureus
Published: June 21, 2026
Comparative efficacy and safety of olezarsen versus volanesorsen for familial chylomicronemia syndrome: a matching-adjusted indirect comparison.
Journal: Journal of comparative effectiveness research
Published: June 19, 2026
The Spanish Atherosclerosis Society Dyslipidaemia Registry: Evolution, real-world evidence, and its role in precision medicine. Current status in 2026.
Journal: Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis
Published: June 17, 2026
Heterozygosity for pathogenic variants in familial chylomicronemia syndrome genes: from carrier state to complex trait.
Journal: Current opinion in lipidology
Published: June 17, 2026
A Case of Familial Chylomicronemia Syndrome Caused by a Novel Homozygous GPIHBP1 Mutation Successfully Treated with the Selective PPARα Modulator Pemafibrate.
Journal: Journal of atherosclerosis and thrombosis
Published: June 17, 2026
ApoC[III] You Later: A Review of Plozasiran for the Management of Familial Chylomicronemia Syndrome.
ApoC[III] You Later: A Review of Plozasiran for the Management of Familial Chylomicronemia Syndrome.
Journal: The Annals of pharmacotherapy
Published: June 06, 2026
ApoC-III Antisense Oligonucleotide Therapy Used in Glycogen Storage Disease Type 1a.
Journal: JACC. Case reports
Published: May 14, 2026
Validation of two familial chylomicronemia syndrome clinical diagnosis scores in a cohort of molecularly defined patients.
Journal: Journal of clinical lipidology
Published: April 24, 2026
Clinical identification of familial chylomicronemia syndrome and novel therapeutic options.
Journal: Expert review of cardiovascular therapy
Published: April 20, 2026
Last Updated: 09/26/2026